Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings are published today in Nature Communications.
For years, Dr. Andréa LeBlanc, Senior Investigator at the LDI and Professor of Neurology and Neurosurgery at McGill University, has strived to identify early neurodegenerative events responsible for age-related memory loss. Her team discovered that the Caspase-6 enzyme is highly activated in Alzheimer disease brain lesions and associated with loss of memory. She, therefore, pursued the hypothesis that stopping Caspase-6 might provide relief from memory loss and stop progressive dementia. Since there are no specific Caspase-6 inhibitors, the LeBlanc team moved upstream, ultimately discovering that Caspase-1 was responsible for activating Caspase-6.
“This was a significant revelation because Caspase-1 inhibitors had been developed for treating inflammatory diseases,” explains Dr. LeBlanc. “Thus, we decided to test the effects of a particular Caspase-1 inhibitor, called VX-765, against memory loss and brain pathologies in a mouse model of Alzheimer disease.”
The work, first authored by Dr. Joseph Flores, a research associate in the LeBlanc lab, showed that VX-765 has an unprecedented beneficial effect in Alzheimer mice. The drug rapidly reverses memory loss, eliminates inflammation, and stops Alzheimer’s prototypical amyloid peptide accumulation in the mice brains. In addition to being safe for humans at relatively high doses for extended periods of time, it is capable of reaching the brain, a significant challenge in the development of drugs against disorders of the brain.
While Dr. LeBlanc cautions that there is a considerable bridge to cross between the mouse brain and that of a human, she believes that since her work has first identified the Caspase-1/Caspase-6 neurodegenerative pathway in human neurons and in human Alzheimer brains, there is a chance that this drug will work just as well in humans as it did in mice. Nevertheless, a clinical trial is needed to determine whether the drug will be beneficial against Alzheimer disease in humans.
Presently, there are no efficient treatments to significantly treat Alzheimer disease, the major affliction in a group of dementias that affect 47.5 million individuals worldwide.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Alzheimers Asso. offers virtual resource fair for caregiverson January 18, 2021 at 11:10 am
The Alzheimer’s Association, Georgia Chapter is hosting a statewide Caregiver Resource Fair, a virtual three-hour program that will help Alzheimer’s and dementia caregivers find local resources and ...
- Alzheimers Q&A: How do you have hope after an Alzheimer's diagnosi?on January 18, 2021 at 4:00 am
Alzheimer’s disease is a truly life-changing illness, not only for the person diagnosed but for their entire family as well.
- Alzheimer’s Awareness Month mitigates social isolation for caregiverson January 16, 2021 at 11:38 pm
2:18 Alzheimers Society of B.C. connects virtually with caregivers to mitigate isolation Naomi Mison has dedicated her life to helping others after her mother was diagnosed with Frontotemporal ...
- Alzheimers Society of B.C. connects virtually with caregivers to mitigate isolationon January 16, 2021 at 6:19 pm
The Alzheimers Society of B.C. is hoping to lighten the load on those diagnosed and their loved ones who become caretakers.
- How did Actor James Doohan Die?on January 16, 2021 at 1:10 pm
According to a close friend and colleague of Doohan’s, he died from complications of pneumonia and Alzheimers, The Seattle Times reported. Doohan publicly announced his Alzheimers diagnosis in ...
- Cognito Therapeutics Receives FDA Breakthrough Device Designation for Next-Generation Digital Therapeutic in Alzheimers Diseaseon January 12, 2021 at 5:00 am
Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders, announced today its lead product ...
- Alzheimers Q&A: What are the warning signs of Alzheimer's disease?on January 11, 2021 at 4:07 am
Alzheimer’s disease is a degenerative brain disorder that has no cure. There's no way to slow or stop its progression, and there's no proven way to prevent it. The disease is named after Dr ...
- ALZHEIMERS ANGEL CENTERon January 9, 2021 at 10:50 pm
Details and information displayed here were provided by this business and may not reflect its current status. We strongly encourage you to perform your own research when selecting a care provider.
- Dame Barbara Windsor’s funeral takes place todayon January 8, 2021 at 2:49 pm
Dame Barbara Windsor’s funeral will take place today. The EastEnders actress died last month following a battle with Alzheimers. Dame Barbara will be cremated at Golders Green Crematorium in ...
via Bing News